GPCR — Structure Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Structure Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -38 | -51.3 | -89.6 | -123 | -141 |
| Depreciation | |||||
| Non-Cash Items | 1.75 | 1.96 | 2.87 | 1.93 | 5.71 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 4.06 | 2.97 | 6.97 | 2.96 | -88 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -32.2 | -46.1 | -79.5 | -117 | -222 |
| Capital Expenditures | -1.21 | -0.155 | -2.17 | -1.29 | -3.61 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 19.1 | -62 | -266 | -358 | 93.4 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 17.9 | -62.1 | -268 | -359 | 89.8 |
| Financing Cash Flow Items | -0.115 | -2.52 | -21.6 | -1.8 | 54.4 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 103 | 29 | 452 | 515 | 763 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 89 | -79.2 | 104 | 39.7 | 630 |